J&J to unload Indian consumer brands; Omega taps new U.K. agency; Bayer moves media-buying business;

> Johnson & Johnson ($JNJ) is selling the Indian rights to two consumer brands, Savlon antiseptic soap and Shower to Shower talcum powder, domestic media reports. Report

> Omega Pharma, currently in the process of selling itself, tapped a new agency to handle its U.K. and Ireland accounts; The Corner nabbed the business. Report

> Bayer moved a $11 million media account in Australia from Mediacom to PHD after a global review; worldwide, Mediacom kept four markets and PHD ended up with the other four, including Australia, Mumbrella says. Report

> ViiiV Healthcare expanded its campaign for HIV prevention and treatment in the U.S. South, funding grassroots outreach projects worth more than $2.8 million. Report

> Big Pharma companies are eyeing government contracts in Brazil, wooed by the market share guarantees offered under the new partnerships. Report

And Finally... Sanofi ($SNY) and Regeneron ($REGN) said they started a new study of their experimental drug dupilumab in atopic dermatitis. Release

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.